Sandeep K Gupta, MD | |
1600 7th Ave S, Birmingham, AL 35233-1711 | |
(205) 638-9918 | |
Not Available |
Full Name | Sandeep K Gupta |
---|---|
Gender | Male |
Speciality | Pediatrics - Pediatric Gastroenterology |
Location | 1600 7th Ave S, Birmingham, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154436616 | NPI | - | NPPES |
350593390-042 | Other | TRICARE-DEACON-350593390 | |
64879869 | Medicaid | KY | |
0074657 | Medicaid | OH | |
000000321535 | Other | ANTHEM-DEAC-350593390 | |
200107770 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0206X | Pediatrics - Pediatric Gastroenterology | 01041280A (Indiana) | Secondary |
2080P0206X | Pediatrics - Pediatric Gastroenterology | MD.45832 (Alabama) | Primary |
Entity Name | University Of Alabama Health Services Foundation, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
The difficulty in replicating and directly comparing and confirming the scientific results reported by researchers worldwide who are studying new approaches to treating spinal cord injuries is slowing the translation of important new findings to patient care.
Many people who are overweight or obese develop insulin resistance and type 2 diabetes at some stage in their lives. A European research team has now discovered that obese people have large amounts of the molecule CXCL5, produced by certain cells in fatty tissue.
Akashi Therapeutics, Inc., announced today that the U.S. Food and Drug Administration has granted Fast Track designation to the company's most advanced product candidate, HT-100 (delayed-release halofuginone), an orally available, small molecule drug candidate intended to reduce fibrosis and inflammation and promote healthy muscle regeneration in boys with DMD.
Glutamine could help people with obesity reduce inflammation of fat tissue and reduce fat mass, according to a new study at Karolinska Institutet in Sweden and the University of Oxford in the U.K. The researchers also show how glutamine levels can alter gene expression in several different cell types.
In an East African opinion piece, U.N. Special Envoy for Malaria Ray Chambers; Mark Green, the director of the Malaria No More Policy Center; and John Bridgeland, vice chairman of Malaria No More, highlight Africans' involvement in addressing malaria on the continent.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Sandeep K Gupta, MD 1600 7th Ave S, Birmingham, AL 35233-1711 Ph: (205) 638-9918 | Sandeep K Gupta, MD 1600 7th Ave S, Birmingham, AL 35233-1711 Ph: (205) 638-9918 |
News Archive
The difficulty in replicating and directly comparing and confirming the scientific results reported by researchers worldwide who are studying new approaches to treating spinal cord injuries is slowing the translation of important new findings to patient care.
Many people who are overweight or obese develop insulin resistance and type 2 diabetes at some stage in their lives. A European research team has now discovered that obese people have large amounts of the molecule CXCL5, produced by certain cells in fatty tissue.
Akashi Therapeutics, Inc., announced today that the U.S. Food and Drug Administration has granted Fast Track designation to the company's most advanced product candidate, HT-100 (delayed-release halofuginone), an orally available, small molecule drug candidate intended to reduce fibrosis and inflammation and promote healthy muscle regeneration in boys with DMD.
Glutamine could help people with obesity reduce inflammation of fat tissue and reduce fat mass, according to a new study at Karolinska Institutet in Sweden and the University of Oxford in the U.K. The researchers also show how glutamine levels can alter gene expression in several different cell types.
In an East African opinion piece, U.N. Special Envoy for Malaria Ray Chambers; Mark Green, the director of the Malaria No More Policy Center; and John Bridgeland, vice chairman of Malaria No More, highlight Africans' involvement in addressing malaria on the continent.
› Verified 3 days ago
Robert Patrick Richter, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-638-9100 | |
Dr. Mary Orr, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-638-9100 Fax: 205-934-7273 | |
Roger Dean Bruce, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2660 10th Ave S, Suite 636, Birmingham, AL 35205 Phone: 205-930-2220 Fax: 205-930-2223 | |
Stephanie Berger, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Mcwane Building Suite 108, Birmingham, AL 35233 Phone: 205-638-2904 | |
Jaime Dion Mckinney, Pediatrics Medicare: Medicare Enrolled Practice Location: 703 Volker Hl, Birmingham, AL 35294 Phone: 205-934-3795 | |
Worth Littlejohn Barbour, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-939-9587 | |
Timothy Todd Fleenor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5004 |